InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-1.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Alles Mark J, Director. Officer active across 4 companies, notably Turning Point Therapeutics, Inc.. Aggregated, 19 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €452k. Activity tracked since 21 June 2021. The latest transaction was filed on 23 May 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Alles Mark J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
2,666 sharesCommon StockSEC:0001209191-23-049977:0
4,190 shares0Common StockSEC:0001209191-23-031964:0
3,625 shares@ US$86.75100.0% of flowCommon StockSEC:0001567619-22-019081:0
Canonical exit: 29 Jan 2023 (T+90)
2,000 shares@ US$76.0035.3% of flowCommon StockSEC:0001209191-22-046273:0
4,980 shares0Common StockSEC:0001567619-22-011784:0
2,300 shares0Common StockSEC:0001567619-22-000661:0
2,000 shares@ US$81.3447.8% of flowCommon StockSEC:0001209191-21-042325:0
Canonical exit: 19 Sept 2021 (T+90)
25,840 sharesCommon StockSEC:0001209191-16-098803:0
11,889 sharesCommon StockSEC:0001209191-16-098803:1
2,634 sharesCommon StockSEC:0001209191-16-094811:0
4,528 sharesCommon StockSEC:0001209191-16-094811:1
2,438 sharesCommon StockSEC:0001209191-16-094811:2
1,266 sharesCommon StockSEC:0001209191-16-094811:3
2,500 sharesCommon StockSEC:0001209191-16-094811:4
1,926 sharesCommon StockSEC:0001209191-16-094811:5
2,292 sharesCommon StockSEC:0001209191-16-094811:6
1,128 sharesCommon StockSEC:0001209191-16-094811:7
1,720 sharesCommon StockSEC:0001209191-16-094811:8
1,506 sharesCommon StockSEC:0001209191-16-094811:9
19 of 19 declarations
About Alles Mark J
Alles Mark J is Administrateur at CELGENE CORP /DE/, and a director at Biomarin Pharmaceutical INC, Turning Point Therapeutics, Inc. and Syros Pharmaceuticals, Inc. The declarant has 19 filings in total, and across the 19 sampled filings between 2016-02-02 and 2023-09-19, the amounts shown are EUR 452452 in buys and EUR 149310 in sells, with Levée d'options as the most frequent transaction nature.
